Watch stocks you care about
The single, easiest way to keep track of all the stocks that matter...
Your own personalized stock watchlist!
It's a 100% FREE Motley Fool service...
Historically, tumultuous times offer some of the best opportunities to unearth killer stocks, and the market's recent mess surely qualifies. And while investing in stocks crossing health care and retail today would be taboo to most, many investors think drugstore operator Rite Aid (NYSE: RAD ) is the exception.
In our Motley Fool CAPS community, about 88% of the 924 investors rating the company are bullish, so there's no shortage of reasons why Rite Aid will thrive, three of which I've highlighted below.
But here at The Motley Fool, we're all for looking at both the good and bad sides of an investment. Once you're done with this article, you can read the case against the stock, weigh in with your own comments below, or rate Rite Aid yourself in CAPS.
1. Bouncing back
Shares of Rite Aid have fought their way back from mere pennies early last year, when many investors had also left stocks like Citigroup and Ford (NYSE: F ) out in the garbage. But with a strong brand and an aging population creating a growing drug demand, some CAPS members think there still may be some juice left and like the odds of Rite Aid continuing its recovery.
2. Making moves
Rite Aid has taken steps to improve its situation, including refinancing debt, slashing costs, and improving its liquidity in an attempt to shore up its finances. And with recent results from retailers like Home Depot (NYSE: HD ) and Sears Holdings (Nasdaq: SHLD ) suggesting the worst may be over, some investors think Rite Aid could benefit significantly if it can turn the corner in time to ride any forthcoming economic turnaround.
3. Takeover target
After Walgreen (NYSE: WAG ) recently agreed to acquire Duane Reade to boost its competitive stance, some CAPS members floated the idea of Rite Aid as a takeover candidate, an opinion recently echoed by a UBS analyst. While investing in buyout speculation can be risky, investors think the whole company or some of its stores could be a good addition to rivals such as Walgreen, CVS Caremark (NYSE: CVS ) , or even Wal-Mart Stores (NYSE: WMT ) .